A detailed history of Pnc Financial Services Group, Inc. transactions in Mannkind Corp stock. As of the latest transaction made, Pnc Financial Services Group, Inc. holds 9 shares of MNKD stock, worth $56. This represents 0.0% of its overall portfolio holdings.

Number of Shares
9
Holding current value
$56
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

BUY
$5.01 - $6.7 $45 - $60
9 New
9 $0
Q1 2024

May 10, 2024

BUY
$3.25 - $5.27 $74 - $121
23 Added 109.52%
44 $0
Q4 2023

Feb 09, 2024

BUY
$3.34 - $4.29 $70 - $90
21 New
21 $0
Q4 2021

Feb 11, 2022

SELL
$4.05 - $5.37 $129 - $171
-32 Reduced 5.84%
516 $2,000
Q3 2021

Nov 05, 2021

SELL
$3.89 - $5.48 $233 - $328
-60 Reduced 9.87%
548 $2,000
Q2 2021

Aug 06, 2021

BUY
$3.61 - $5.45 $2,194 - $3,313
608 New
608 $3,000
Q1 2018

May 11, 2018

SELL
$2.28 - $3.8 $2,849 - $4,750
-1,250 Closed
0 $0
Q4 2017

Feb 09, 2018

BUY
$2.28 - $6.71 $2,849 - $8,387
1,250
1,250 $0

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.61B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Pnc Financial Services Group, Inc. Portfolio

Follow Pnc Financial Services Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pnc Financial Services Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Pnc Financial Services Group, Inc. with notifications on news.